We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Tivicay and Tivicay PD
Australian Public Assessment Report
Device/Product Name
Tivicay and Tivicay PD
Active ingredients
Dolutegravir (as sodium)
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-03495-1-2
Submission Type
Extension of indications, and new dose form
Decision
Approved